2021
DOI: 10.2174/1874364102115010054
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Visual, Refractive and Topographic Outcomes of KeraRings Combined with Accelerated Transepithelial Crosslinking for Management of Different Grades of Progressive Keratoconus: A Retrospective Cohort Study

Abstract: Purpose: To evaluate long-term visual, refractive, and topographic outcomes of KeraRings intrastromal implantation combined with accelerated transepithelial cross-linking for management of different stages of progressive keratoconus. Materials and Methods: This retrospective cohort study included 70 eyes of 70 patients with Amsler-Krumeich grades 1 to 4 keratoconus. They were divided into two groups: group-A included … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 59 publications
0
1
0
Order By: Relevance
“…Success of the surgical procedure and the improvement of vision with ICRS depend on essential factors, such as precise positioning, correct implantation depth, and suitable diameter of the optical zone. The types of ICRS used for KCN management include Keraring (Mediphacos Inc., Belo Horizonte, Brazil), Intacs (Addition Technology, Sunnyvale, CA, USA), Intacs SK (Addition Technology Inc., Lombard, IL, USA), MyoRing (Dioptex GmbH, Linz, Austria), and Ferrara (Ferrara Ophthalmics, Belo Horizonte, Brazil) [ 58 - 61 ] .…”
Section: Resultsmentioning
confidence: 99%
“…Success of the surgical procedure and the improvement of vision with ICRS depend on essential factors, such as precise positioning, correct implantation depth, and suitable diameter of the optical zone. The types of ICRS used for KCN management include Keraring (Mediphacos Inc., Belo Horizonte, Brazil), Intacs (Addition Technology, Sunnyvale, CA, USA), Intacs SK (Addition Technology Inc., Lombard, IL, USA), MyoRing (Dioptex GmbH, Linz, Austria), and Ferrara (Ferrara Ophthalmics, Belo Horizonte, Brazil) [ 58 - 61 ] .…”
Section: Resultsmentioning
confidence: 99%